Briefly, ATDC5 cells were treated twice with 0.1 M Dox (48 h treatment interval), and senescent chondrocytes were established after 4 days of stimulation
LPS, lipopolysaccharides
Most research uses in vitro cell cultures or rodent models
Free Radicals in Biology and Medicine (5th ed.)
April 29, 2026 January 29, 2026 January 27, 2026 January 18, 2026 January 14, 2026 December 21, 2025 December 16, 2025 December 12, 2025 November 18, 2025 November 12, 2025 November 10, 2025 November 6, 2025 November 1, 2025 October 31, 2025 October 29, 2025 October 24, 2025 October 19, 2025 October 13, 2025 October 11, 2025 September 30, 2025 September 29, 2025 September 26, 2025 September 23, 2025 September 17, 2025 September 10, 2025 September 10, 2025 September 10, 2025 September 10, 2025 September 3, 2025 August 25, 2025 August 22, 2025 July 22, 2025 July 8, 2025 May 14, 2025
The STEP program trials with semaglutide (a GLP-1-only agonist) and the SURMOUNT trials with tirzepatide (dual GIP/GLP-1 agonist) represent the strongest weight loss efficacy data in the history of pharmacotherapy for obesity
